{
  "report_rows": [
    {
      "kpi": "Total Revenue (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$988M vs. cons $990M",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.98 vs. cons $0.958",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "NA EBIT Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~22.5% vs. cons 20.9%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adj. EPS FY 2026 (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide reaffirm $3.85 mid vs. cons $3.767",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "NA Segment Margin FY 2026 (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide reaffirm ~24% vs. cons 23.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "China Revenue FY 2026 (FY 2026)",
      "prediction": "LOWER",
      "answer": "guide risk of widening to mid-teens decline vs. cons ~-11%",
      "confidence": "LOW"
    },
    {
      "kpi": "Q3 2026 EPS qualitative (Q3 2026)",
      "prediction": "BETTER",
      "answer": "guide implies ~$1.00-1.05 vs. cons $0.959",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 2.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 H2 estimate revisions from FY guide reaffirmation drive modest follow-through; partially offset by short-covering exhaustion after large pre-run",
  "day5_confidence": "MEDIUM"
}